ATHA
Athira Pharma Inc.
Company Overview
| Mkt Cap | $15.26M | Price | $4.13 |
| Volume | 6.88K | Change | -0.60% |
| P/E Ratio | -0.2 | Open | $3.95 |
| Revenue | -- | Prev Close | $4.16 |
| Net Income | $-96.9M | 52W Range | $2.20 - $8.26 |
| Div Yield | N/A | Target | $4.00 |
| Overall | 45 | Value | 60 |
| Quality | 23 | Technical | 54 |
No chart data available
Stock Overview
Updated DailyAthira Pharma Inc. (ATHA) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $4.13 with a market capitalization of $15.26 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows ATHA with a volume of 7K shares. The stock opened down 4.93% from yesterday's close of $4.16. Current analyst estimates project earnings of $NA per share for this year, with next year targeting $NA.
ATHA demonstrates neutral technical outlook based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ATHA include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -3.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 4, 2025 at 05:08 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATHA | $4.13 | -0.6% | 6.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |